Triple-negative breast cancer (TNBC) is defined by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER-2) expression [4]. This evidence concerns the gene PGR and triple-negative breast carcinoma.